Pneumrx

 
 

News & Press Releases

PneumRx, a BTG International group company, is focused on developing minimally invasive solutions for unmet medical needs in pulmonary medicine. Please click on a link below to learn more about PneumRx and PneumRx Coils, or to find us at our next conference or event.

 

PneumRx Gets CE Mark for Lung Volume Reduction Coil System

October 13, 2010

PneumRX has received CE Marking for its RePneu Lung Volume Reduction Coil System to treat late stage emphysema. The device is designed to implant coils into the lungs to compress damaged tissue and restore elasticity in healthier lung tissue. The system is a minimally invasive alternative to surgery, according to the company. PneumRX intends to launch the product in Europe later this year.

Read Press Release